ISDA published a statement urging European authorities toward a more effective course of action to deal with the procyclicality that causes market risk capital requirements to balloon during a period of stress. To ease the impact of recent market volatility, ECB has temporarily reduced the qualitative market risk multiplier, which is not directly linked to the number of back-testing exceptions that are causing the problem. ISDA, however, states that a more effective course of action would be to revise the Capital Requirements Regulation in EU to bring it in line with the Basel Committee standards by giving national competent authorities the flexibility to take appropriate action when exceptions are not caused by deficiencies in the model. This would allow national authorities to intervene where necessary to temporarily suspend the automatic effects of the multiplier until the extreme effects of the COVID-19 pandemic are over.
Regulators have typically tried to avoid putting in place measures that are explicitly procyclical, but the recent bout of COVID-related volatility is resulting in a significant increase in trading book capital requirements that could impede the ability of banks to deploy capital in support of the economy. The issue centers on the elevated number of value-at-risk (VaR) back-testing exceptions that banks are experiencing, caused by severe market volatility due to the pandemic. Under the current regime introduced as part of Basel 2.5, banks are required to add a multiplier to their capital calculations if actual or hypothetical P&L over the course of a single trading day exceeds VaR estimates more than four times in a year—with the multiplier increasing as the number of exceptions continues to climb. However, this measure has proved to be highly procyclical. The multiplier is meant to compensate for model deficiencies, but extreme volatility in recent weeks has put VaR models under pressure, resulting in a higher number of exceptions. This means banks are having to apply multipliers because of market volatility rather than shortcomings in their models, causing market risk capital requirements to balloon during a period of stress.
All of this is happening at a time when regulators are taking measures to encourage banks to use excess capital and liquidity to continue to provide intermediation services and support the economy. The procyclical nature of the VaR multiplier could end up having the opposite effect, putting pressure on capital requirements. Regulators in Canada, Switzerland, and the UK have recognized this issue and have taken action to smooth the volatility-induced procyclical effect of the multiplier. For example, Swiss regulators have opted to freeze the multiplier used by banks as of February 1 until July 1. ECB has also looked to address the problem and announced that it is temporarily reducing the "qualitative market risk multiplier," a measure set by supervisors that is intended to address weaknesses in a bank’s risk management, controls, and governance framework. While this action is welcome, ISDA would urge the European authorities to go further. The qualitative multiplier indirectly linked to the number of back-testing exceptions causing the problem. It is also individual to each bank, meaning the potential level of relief could differ between firms and be limited in some cases.
Therefore, ISDA believes that a more effective course of action would be to revise the Capital Requirements Regulation in EU to bring it in line with the Basel Committee standards by giving national competent authorities the flexibility to take appropriate action when exceptions are not caused by deficiencies in the model. This would allow national authorities to intervene where necessary to temporarily suspend the automatic effects of the multiplier until the extreme effects of the COVID-19 outbreak are over. It is important that banks have sufficient capital to weather the current crisis and the more than EUR 2 trillion in tier 1 capital that internationally active banks have added to their balance sheets since 2011 means they are more resilient to stress. However, the procyclical market risk capital measures give banks less leeway to act as intermediaries, hindering firms from accessing the financing and risk management services they need.
Related Link: Statement
Keywords: International, Europe, EU, Banking, COVID-19, Value-at-Risk, CRR, Procyclicality, Basel, Market Risk, Regulatory Capital, Backtesting Exception, ISDA
HKMA announced that enhancements will be made to the Special 100% Loan Guarantee of the SME Financing Guarantee Scheme (SFGS) and the application period will be extended to December 31, 2021.
BoE has set out a three-phased plan to transform data collection from the UK financial sector over the next decade.
BIS recently made a couple of announcements with respect to the planned and ongoing work in the area of financial technology.
ESRB updated the list of national macro-prudential measures applied by each member state in the European Economic Area.
BoE has set out results of a survey on the impact of COVID-19 events on the use of machine learning and data science.
In response to a request from the European Council and Parliament, ECB published an opinion on the proposed regulation on markets in crypto-assets.
APRA announced the updated aggregate amounts for the 2021 Committed Liquidity Facility (CLF) established between the Reserve Bank of Australia (RBA) and certain locally incorporated authorized deposit-taking institutions that are subject to the Liquidity Coverage Ratio (LCR).
ECB published supervisory Memorandums of Understanding (MoUs) with UK as well as other European and non-European authorities.
EIOPA identified business model sustainability and adequate product design as the two EU-wide strategic supervisory priorities.
After considering comments received on the November 2020 proposal, US Agencies (FDIC, FED and OCC) are proceeding with the proposed revisions to the reporting forms and instructions for Call Reports FFIEC 031, FFIEC 041, and FFIEC 051.